Financial Performance - The company's operating revenue for 2021 was CNY 2,898,620,127.51, representing a 48.51% increase compared to CNY 1,951,739,654.33 in 2020[28]. - The net profit attributable to shareholders for 2021 was CNY 278,002,762.25, a significant increase of 173.12% from CNY 101,788,898.88 in 2020[28]. - The net cash flow from operating activities for 2021 was CNY 179,826,694.49, up 124.42% from CNY 80,131,156.55 in 2020[28]. - The total assets at the end of 2021 were CNY 3,505,661,570.30, which is a 43.41% increase from CNY 2,444,422,830.64 at the end of 2020[28]. - The basic earnings per share for 2021 was CNY 1.20, reflecting a 135.29% increase compared to CNY 0.51 in 2020[30]. - The weighted average return on equity for 2021 was 16.89%, an increase of 8.93 percentage points from 7.96% in 2020[30]. - The company reported a net profit of CNY 102,744,380.86 in Q4 2021, which was the highest quarterly profit for the year[33]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for 2021 was CNY 274,637,035.91, a 241.70% increase from CNY 80,372,674.74 in 2020[28]. - The company's net assets attributable to shareholders at the end of 2021 were CNY 2,036,892,273.07, a 52.82% increase from CNY 1,332,877,495.55 at the end of 2020[28]. Dividend Distribution - The company plans to distribute a cash dividend of 2.50 RMB per 10 shares, totaling approximately 67.44 million RMB based on the total share capital of 269,750,994 shares as of December 31, 2021[7]. - The company does not plan to issue stock dividends or increase capital reserves through stock distribution for the 2021 profit distribution plan[7]. - The company’s remaining undistributed profits will be carried forward to the next fiscal year after the implementation of the profit distribution plan[7]. Audit and Compliance - The company has received a standard unqualified audit report from Lixin Certified Public Accountants, ensuring the accuracy and completeness of the financial report[6]. - The company’s board of directors has confirmed the authenticity and completeness of the annual report, with all members present at the meeting[5]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[9]. - The company has not encountered any violations in decision-making procedures regarding external guarantees[9]. - The company’s financial report has been signed and sealed by the responsible persons, ensuring its validity[6]. Risk Management - The company has outlined potential risks in its future development, which are detailed in the management discussion and analysis section of the report[9]. - The company emphasizes the importance of investor awareness regarding the risks associated with forward-looking statements in the report[8]. Market and Industry Trends - The fluorochemical industry is projected to exceed 640,000 tons in total production capacity and over 1,000 billion yuan in total output value by 2025[49]. - The demand for fluorinated materials is expected to continue increasing due to growth in sectors such as semiconductors, new energy vehicles, and healthcare[53]. - The fluorochemical industry in China is projected to exceed a total production capacity of 6.4 million tons, with sales revenue surpassing ¥100 billion, highlighting its strategic importance in the national economy[110]. Research and Development - The company has completed 43 registered patents, including 15 invention patents, enhancing its technological innovation capabilities[48]. - Research and development expenses rose by 75.74% to 28.78 million RMB, indicating increased investment in product and technology development[81]. - The company has increased its R&D investment and expanded its R&D team, focusing on the development of fluoropolymer, fluorochemical products, and resource utilization technologies[138]. - The company collaborates with universities to develop alternative synthesis technologies for PFOA and resource utilization technologies for by-products[139]. Production and Capacity - The company has a production capacity of 85 thousand tons per year for anhydrous hydrofluoric acid, contributing to its competitive position in the market[53]. - The company’s main business revenue was 2.785 billion yuan, an increase of 47.61% year-on-year, with export revenue reaching 1.494 billion yuan, up 111.89%[45]. - The production capacity for fluorocarbon chemicals is designed at 125,000 tons per year, with a utilization rate of 79.55%[165]. - The company aims to enhance production capacity and diversify product offerings, focusing on high-end fluoropolymer materials and fluorocarbon chemicals, while also exploring upstream methane chlorides and chlor-alkali businesses[188]. Financial Management - The company's total cash inflow from financing activities was ¥954.64 million, up 129.40% from ¥416.15 million in 2020[105]. - The company's financial expenses decreased by 52.64%, mainly due to reduced bank loan interest costs[81]. - The company plans to raise up to 800 million yuan through the issuance of convertible bonds to fund the construction of two projects and supplement working capital[199]. - The company aims to enhance its indirect financing capabilities and optimize its capital structure through strengthened bank-enterprise cooperation[199]. Environmental and Safety Management - The company emphasizes safety and environmental risk management, implementing comprehensive safety production systems and regular inspections[44]. - The company is committed to improving safety and environmental protection systems, aiming for zero penalties and zero consultations in safety and environmental matters throughout the year[195]. Strategic Initiatives - The company plans to deepen management reforms and enhance team building to adapt to rapid growth, including strategic cooperation with management consulting firms[196]. - The company intends to strengthen brand recognition and expand market share by enhancing sales team capabilities and optimizing sales channels domestically and internationally[194].

2021 年第三季度报告 单位：元 币种：人民币 证券代码：605020 证券简称：永和股份 浙江永和制冷股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财 务报表信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 本报告期 年初至报告 | --- | --- | --- | --- | --- | |-----------------------------------------------|----------------|----------------------------------|------------------|----------------------- ...

Financial Performance - The company's operating revenue for the first half of 2021 reached ¥1,260,580,957.97, representing a year-on-year increase of 31.50%[26]. - Net profit attributable to shareholders was ¥108,231,155.85, up 68.58% compared to the same period last year[26]. - The net profit after deducting non-recurring gains and losses was ¥103,929,248.01, reflecting a significant increase of 118.72% year-on-year[26]. - The net cash flow from operating activities was ¥99,264,637.20, which is a 66.07% increase compared to the previous year[26]. - Basic earnings per share rose to ¥0.54, marking a 68.75% increase from ¥0.32 in the same period last year[27]. - The company's total assets increased by 13.80% year-on-year, reaching ¥2,781,679,665.91[28]. - The net assets attributable to shareholders grew by 8.33% to ¥1,443,903,035.63[28]. - Operating revenue increased by 31.50% to CNY 1,260,580,957.97 compared to CNY 958,616,673.84 in the same period last year[78]. - Operating costs rose by 31.44% to CNY 992,983,644.41, primarily due to increased sales volume[78]. - Research and development expenses surged by 106.59% to CNY 17,407,502.67, reflecting a significant increase in R&D investment[78]. Industry Position and Market Trends - The company is positioned in the fluorochemical industry, which is a key component of China's strategic emerging industries[34]. - The total production capacity of various fluorochemical products in China is expected to exceed 6.4 million tons, with a total output surpassing 4.5 million tons[34]. - China's fluorite resources account for approximately 13.55% of global reserves, with a production of about 4.3 million tons in 2020, representing 57% of the world's total output[39]. - The production capacity of anhydrous hydrofluoric acid in China reached 253.1 thousand tons/year in 2020, with an actual production of approximately 131.6 thousand tons, indicating a low concentration of production capacity among enterprises[40]. - The total production of fluorinated refrigerants in China during the first half of the year was approximately 750 thousand tons, reflecting a year-on-year growth of about 28%[45]. - The price of various types of fluorinated refrigerants increased by 5% to 110% compared to the same period last year, with the exception of HFC-32[45]. Production Capacity and Operations - The company currently holds an annual production capacity of 85 thousand tons for anhydrous hydrofluoric acid and over 100 thousand tons for various fluorinated refrigerants[40][45]. - The company has an annual production capacity of 12.8 thousand tons for fluoropolymer materials and monomers[49]. - The annual production capacity for fluorite powder is 80,000 tons, hydrogen fluoride is 85,000 tons, and fluorocarbon chemicals exceeds 100,000 tons, with a production capacity of 12,800 tons for fluoropolymer materials[62]. - The company has a significant self-supply advantage in raw materials, ensuring continuous production and operational stability[61]. - The company employs a "sales-driven production" model, adjusting production based on market demand and customer orders[57]. Research and Development - The company is committed to increasing R&D investment and professional talent reserves to improve its technological capabilities[62]. - The company has a strong focus on R&D, with significant investments aimed at enhancing its innovation capabilities and achieving rapid transformation of research outcomes[73]. - The company's FEP product technology is domestically leading, with a total of 33 registered patents, including 13 invention patents[73]. Environmental and Safety Compliance - The company has implemented a comprehensive safety and environmental risk management system to ensure stable production operations[72]. - The company has not reported any major environmental pollution incidents during the reporting period, maintaining compliance with national emission standards[106]. - The company has established 25 environmental pollution control facilities in Inner Mongolia, 5 in Huasheng Hydrofluoric Acid, 4 in Huasheng Fluorspar, and 10 in Jinhua Yonghe, all operating at 100% capacity[113]. - The company has implemented a series of energy management plans to reduce carbon emissions, including the construction of multiple water reuse systems to enhance water recovery rates[120]. Shareholder Commitments and Governance - The company has committed to a 36-month lock-up period for major shareholders, during which they will not transfer or manage their shares[128]. - The company has a commitment to disclose any failure to fulfill promises in a timely manner[133]. - The company will publicly explain any failure to implement stock price stabilization measures and apologize to shareholders[145]. - The company will ensure that all related party transactions are conducted at fair market conditions[161]. - The controlling shareholder guarantees no engagement in competitive business activities with the company's main operations[161]. Financial Management and Commitments - The company will ensure the effective use of raised funds and implement projects that align with its main business to boost competitiveness and profitability[153]. - A profit distribution policy will be established to ensure reasonable and stable returns for investors, with a focus on feedback from independent directors and minority shareholders[153]. - The company will compensate for any losses caused to shareholders or investors due to unfulfilled commitments, including using cash dividends for this purpose[172]. - The company has not engaged in any significant related transactions that require disclosure during the reporting period[182].